Right now the price per share is 30,82$, In this post we are going to talk about the listed company Pacira Pharmaceuticals Inc, its leaders are Charles A. Reinhart (Chief Financial Officer), Charles Anthony Laranjeira (Chief Technical Officer), David M. Stack (Chairman, Chief Executive & Operating Officer), Jonathan Slonin (Chief Clinical Officer), Roy Winston (Chief Medical Officer), they lead it to work in Biotechnology: Pharmaceutical Preparations especially in the North America region.
Yesterday this stock ended the day with a value of desconocido$.
The current range on the same day is from 30,70$ - 31,57$, with a percentage difference of 31,14$ quite wide that helps to be able to do day trading.
The company has an annual revenue of desconocido.
The opening price that appears as last recorded is desconocido.
One of the most interesting values to assess whether the price of a share is low or high is the minimum and maximum price of the last 52 weeks, in this case it has varied between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].
Buscar
